期刊文献+

强直性脊柱炎全髋关节置换术后髋关节满意度评价及影响因素分析

Evaluation of hip satisfaction and influencing factors following total hip arthroplasty in patients with ankylosing spondylitis
下载PDF
导出
摘要 目的:评估强直性脊柱炎(AS)合并髋关节终末期受累患者接受全髋关节置换术(THA)后髋关节满意度,并分析其影响因素。方法:回顾性分析2006年1月至2021年12月行THA的AS合并髋关节终末期受累患者462例(658髋)的临床资料。根据末次随访患者对髋关节满意度的评价结果分为满意组(492髋)和不满意组(166髋),收集并比较患者的基线资料、人口学数据、疾病相关数据、髋关节及手术相关参数,及实验室检查结果。将单因素分析结果中差异有统计学意义(P<0.05)的因素纳入多因素logistic回归分析,分析髋关节满意度的影响因素。结果:随访时间为17~208个月,平均(108.3±50.2)个月。末次随访患者对髋关节满意度的评价结果显示,48.0%(316髋)为非常满意、26.7%(176髋)为比较满意、19.1%(126髋)为较不满意、6.1%(40髋)为非常不满意,患者髋关节总满意度为74.8%。髋关节评价不满意的主要原因包括关节活动度受限、跛行、双下肢不等长、疼痛及并发症。多因素logistic回归分析结果提示,吸烟史[风险比(OR)=0.634,P=0.047]、风湿性疾病合并症指数(OR=1.610,P<0.001)、使用大直径球头(OR=0.550,P=0.007)和使用陶瓷对陶瓷关节面(OR=0.584,P=0.008)是导致髋关节评价不满意的独立危险因素。结论:AS合并髋关节终末期受累患者接受THA术后的髋关节满意度较高。其中,关节活动受限是导致髋关节评价不满意的首要原因。围手术期管理需要密切关注与髋关节满意度相关的影响因素,包括吸烟史、内科合并症及假体选择。 Objective:To evaluate total hip satisfaction in ankylosing spondylitis(AS)with end-stage hip involvement after total hip replacement(THA)and analyze the influencing factors.Methods:A retrospective analysis was conducted on clinical data from 464 AS patients(658 hips)with end-stage hip involvement who underwent THA between January 2006 and December 2021.Based on satisfaction at the last follow-up,patients were divided into the satisfactory group(350 cases,492 hips)and the dissatisfactory group(114 cases,166 hips).Baseline characteristics,demographic data,disease-related data,hip and surgery-related parameters,and laboratory results were collected and compared between the two groups.Factors with statistical significance(P<0.05)in the univariate analysis were included in a multivariate logistic regression analysis to assess the factors influencing patient satisfaction with the hip joint.Results:The follow-up period ranged from 17 to 208 months,with an average of(108.3±50.2)months.Evaluation of the hip satisfaction at the last follow-up showed that48.0%(316 hips)were very satisfactory,26.7%(176 hips)were relatively satisfactory,19.1%(126 hips)were less satisfied,6.1%(40 hips)were very unsatisfactory,and the total hip satisfaction was 74.8%.The main reasons for unsatisfactory hip evaluation include limited joint mobility,claudication,unequal length of both lower limbs,pain and complications.The multivariate logistic regression model revealed that smoking history(OR=0.634,P=0.047),rheumatic disease comorbidity index(odds ratio[OR]=1.610,P<0.001),use of a large-diameter femoral head(OR=0.550,P=0.007),and use of a ceramicon-ceramic bearing surface(OR=0.584,P=0.008)were independent risk factors for patient dissatisfaction.Conclusions:AS patients with end-stage hip involvement have high satisfaction after THA.Limited mobility is the primary reason for postoperative dissatisfaction.Therefore,perioperative management should focus on factors related to postoperative dissatisfaction,including smoking history,medical complications,and prosthesis selection.
作者 李春跃 郭邵逸 崔永虹 满斯亮 张浩天 刘伟 张亮 LI Chunyue;GUO Shaoyi;CUI Yonghong;MAN Siliang;ZHANG Haotian;LIU Wei;ZHANG Liang(Department of Anesthesiology,Beijing Jishuitan Hospital,Capital Medical University,Beijing 100035,China;Department of Orthopaedic Surgery,Beijing Jishuitan Hospital,Capital Medical University,Beijing 100035,China;Department of Rheumatology and Immunology,Sinopharm Tongmei General Hospital,Datong 037001,China;Department of Rheumatology and Immunology,Beijing Jishuitan Hospital,Capital Medical University,Beijing 100035,China)
出处 《中华骨与关节外科杂志》 CSCD 北大核心 2024年第5期404-409,共6页 Chinese Journal of Bone and Joint Surgery
基金 北京积水潭医院自然基金培育计划(ZR-202416)。
关键词 强直性脊柱炎 全髋关节置换术 髋关节满意度 关节活动度 Ankylosing Spondylitis Total Hip Arthroplasty Hip Satisfaction Range of Motion
  • 相关文献

参考文献4

二级参考文献78

  • 1Zochling J, van der Heijde D, Burgos-Vargas R, et al. ASAS/ EULAR recommendations for the management of ankylos- ing spondylitis. Ann Rheum Dis, 2006, 65: 442-452.
  • 2Khan MA. Update on spondyloarthropathies. Ann Intern Med, 2002, 136: 896-907.
  • 3Sieper J, Braun J, Rudwaleit M, et al. Ankylosing spondyli- tis: an overview. Ann Rheum Dis, 2002, 61 Suppl 3: iii8-18.
  • 4Sieper J, Appel H, Braun J, et al. Critical appraisal of assess- ment of structural damage in ankylosing spondylitis: impli- cations for treatment outcomes. Arthritis Rheum, 2008, 58: 649-656.
  • 5Lories R J, Derese L, de Bail C, et al. Evidence for uncou- pling of inflammation and joint remodeling in a mouse mod- el of spondylarthritis. Arthritis Rheum, 2007, 56:489-497.
  • 6Maillefert JF, Aho S, E1 Maghraoui A, et al. Changes in bone density in patients with ankylosing spondylitis: a 2 year follow-up study. Osteoporos Int, 2001, 12: 605-609.
  • 7Gratacos J, Collado A, Pons F, et al. Significant loss of bone mass in patients with early, active ankylosing spondylitis. A follow-up study. Arthritis Rheum, 1999, 42: 2319-2324.
  • 8Visvanathan S, van der Heijde D, Deodhar A, et al. Effects of infliximab on markers of inflammation and bone turnover and associations with bone mineral density in patients with ankylosing spondylitis. Ann Rheum Dis, 2009, 68: 75-182.
  • 9Allali F, Breban M, Porcher R, et al. Increase in bone miner- al density of patients with spondyloarthropathy treated with anti-tumour necrosis factor alpha. Ann Rheum Dis, 2003, 62: 347-349.
  • 10Briot K, Gossec L, Kolta S, et al. Prospective assessment of body weight, body composition, and bone density changes in patients with spondyloarthropathy receiving anti-tumor necrosis factor-a treatment. J Rheumatol, 2008, 35:855-861.

共引文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部